COVID-19 and hyperglycemia/diabetes
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved..
In early studies regarding coronavirus disease 2019 (COVID-19), type 2 diabetes mellitus was considered to contribute substantially to the disease's inflammatory response. Subsequently, even hyperglycemia, regardless of insulin resistance or diabetes mellitus, was found to be additionally harmful. Recent studies have shown inflammation of the pancreatic β cells in COVID-19, even leading to new onset diabetes mellitus. We hereby summarize core literature on glycemia and COVID-19, and present implicated pathways and mechanisms.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
World journal of diabetes - 12(2021), 5 vom: 15. Mai, Seite 642-650 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Michalakis, Konstantinos [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 18.05.2021 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.4239/wjd.v12.i5.642 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM325471304 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM325471304 | ||
| 003 | DE-627 | ||
| 005 | 20231225192516.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4239/wjd.v12.i5.642 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1084.xml |
| 035 | |a (DE-627)NLM325471304 | ||
| 035 | |a (NLM)33995851 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Michalakis, Konstantinos |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 and hyperglycemia/diabetes |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 18.05.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. | ||
| 520 | |a In early studies regarding coronavirus disease 2019 (COVID-19), type 2 diabetes mellitus was considered to contribute substantially to the disease's inflammatory response. Subsequently, even hyperglycemia, regardless of insulin resistance or diabetes mellitus, was found to be additionally harmful. Recent studies have shown inflammation of the pancreatic β cells in COVID-19, even leading to new onset diabetes mellitus. We hereby summarize core literature on glycemia and COVID-19, and present implicated pathways and mechanisms | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Glucose | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Inflammation | |
| 650 | 4 | |a Risk factors | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Ilias, Ioannis |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t World journal of diabetes |d 2010 |g 12(2021), 5 vom: 15. Mai, Seite 642-650 |w (DE-627)NLM207896593 |x 1948-9358 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2021 |g number:5 |g day:15 |g month:05 |g pages:642-650 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4239/wjd.v12.i5.642 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2021 |e 5 |b 15 |c 05 |h 642-650 | ||